Success Metrics

Clinical Success Rate
81.5%

Based on 22 completed trials

Completion Rate
81%(22/27)
Active Trials
40(53%)
Results Posted
73%(16 trials)
Terminated
5(7%)

Phase Distribution

Ph phase_2
27
36%
Ph phase_4
1
1%
Ph phase_3
5
7%
Ph not_applicable
10
13%
Ph phase_1
22
29%
Ph early_phase_1
5
7%

Phase Distribution

27

Early Stage

27

Mid Stage

6

Late Stage

Phase Distribution70 total trials
Early Phase 1First-in-human
5(7.1%)
Phase 1Safety & dosage
22(31.4%)
Phase 2Efficacy & side effects
27(38.6%)
Phase 3Large-scale testing
5(7.1%)
Phase 4Post-market surveillance
1(1.4%)
N/ANon-phased studies
10(14.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

71.0%

22 of 31 finished

Non-Completion Rate

29.0%

9 ended early

Currently Active

40

trials recruiting

Total Trials

75

all time

Status Distribution
Active(41)
Completed(22)
Terminated(9)
Other(3)

Detailed Status

Recruiting24
Completed22
Active, not recruiting16
Terminated5
Withdrawn4
unknown2

Development Timeline

Analytics

Development Status

Total Trials
75
Active
40
Success Rate
81.5%
Most Advanced
Phase 4

Trials by Phase

Early Phase 15 (7.1%)
Phase 122 (31.4%)
Phase 227 (38.6%)
Phase 35 (7.1%)
Phase 41 (1.4%)
N/A10 (14.3%)

Trials by Status

active_not_recruiting1621%
completed2229%
not_yet_recruiting11%
recruiting2432%
suspended11%
terminated57%
unknown23%
withdrawn45%

Recent Activity

Clinical Trials (75)

Showing 20 of 75 trialsScroll for more
NCT07293247Phase 2

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

Recruiting
NCT05675410Phase 3

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

Recruiting
NCT05976763Phase 3

Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma

Recruiting
NCT03811015Phase 3

Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer

Active Not Recruiting
NCT07605416Phase 2

Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial

Recruiting
NCT07621614Phase 2

A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information

Recruiting
NCT06179303Phase 2

Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

Recruiting
NCT07089641Phase 1

ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial

Recruiting
NCT04665739Phase 2

Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors

Recruiting
NCT04293562Phase 3

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Recruiting
NCT05892393Phase 1

Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple Myeloma

Recruiting
NCT04166318Phase 2

Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study

Active Not Recruiting
NCT05710328Phase 2

Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial

Active Not Recruiting
NCT04316117Phase 2

Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study

Active Not Recruiting
NCT05886036Phase 2

Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial

Recruiting
NCT06820957Phase 2

Testing a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing Sarcoma Who Have Cancer That Has Spread to Other Parts of the Body

Active Not Recruiting
NCT03604315Phase 1

Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF

Recruiting
NCT01934660

Links Between Inflammation and Cardiometabolic Diseases

Completed
NCT04333537Phase 2

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

Recruiting
NCT07463807Phase 1

Testing the Investigational Medication Combination of Teclistamab and Pomalidomide Compared to the Usual Treatment (Carfilzomib, Pomalidomide, and Dexamethasone) for Patients With Multiple Myeloma Who Have Relapsed Shortly After Treatment

Recruiting

Drug Details

Intervention Type
OTHER
Total Trials
75